These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 17164128)
1. Cyclic AMP-dependent modulation of cardiac L-type Ca2+ and transient outward K+ channel activities by epoxyeicosatrienoic acids. Xiao YF Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):11-8. PubMed ID: 17164128 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of cardiac L-type Ca2+ currents in transgenic mice with cardiac-specific overexpression of CYP2J2. Xiao YF; Ke Q; Seubert JM; Bradbury JA; Graves J; Degraff LM; Falck JR; Krausz K; Gelboin HV; Morgan JP; Zeldin DC Mol Pharmacol; 2004 Dec; 66(6):1607-16. PubMed ID: 15361551 [TBL] [Abstract][Full Text] [Related]
3. Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms. Lu T; Ye D; Wang X; Seubert JM; Graves JP; Bradbury JA; Zeldin DC; Lee HC J Physiol; 2006 Sep; 575(Pt 2):627-44. PubMed ID: 16793897 [TBL] [Abstract][Full Text] [Related]
4. Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium. Vriens J; Owsianik G; Fisslthaler B; Suzuki M; Janssens A; Voets T; Morisseau C; Hammock BD; Fleming I; Busse R; Nilius B Circ Res; 2005 Oct; 97(9):908-15. PubMed ID: 16179585 [TBL] [Abstract][Full Text] [Related]
19. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. Xu X; Zhang XA; Wang DW Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627 [TBL] [Abstract][Full Text] [Related]
20. Roles of epoxyeicosatrienoic acids in vascular regulation and cardiac preconditioning. Gauthier KM; Yang W; Gross GJ; Campbell WB J Cardiovasc Pharmacol; 2007 Dec; 50(6):601-8. PubMed ID: 18091575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]